...
机译:优化资格标准和临床试验,以提高原发性脑肿瘤患者的临床试验
Dana Farber Canc Inst Boston MA 02215 USA|Harvard Med Sch Boston MA 02115 USA;
Univ Hosp Zurich Switzerland|Univ Zurich Zurich Switzerland;
US FDA Off Hematol & Oncol Prod Ctr Drug Evaluat & Res Silver Spring MD USA;
Hosp Univ Penn 3400 Spruce St Philadelphia PA 19104 USA;
H Lee Moffitt Canc Ctr & Res Inst Tampa FL USA;
Erasmus Univ Hosp Rotterdam Netherlands;
Cleveland Clin Cleveland OH 44106 USA;
Washington Univ St Louis MO 63110 USA;
Mayo Clin Rochester MN USA;
NCI Neurooncol Branch NIH Bethesda MD 20892 USA;
Johns Hopkins Sidney Kimmel Comprehens Canc Ctr Baltimore MD USA;
Wake Forest Baptist Comprehens Canc Ctr Winston Salem NC USA;
Univ Pittsburgh Pittsburgh PA USA;
Miami Canc Inst Miami FL USA;
NCI Neurooncol Branch NIH Bethesda MD 20892 USA;
Johns Hopkins Sidney Kimmel Comprehens Canc Ctr Baltimore MD USA;
Wake Forest Baptist Comprehens Canc Ctr Winston Salem NC USA;
H Lee Moffitt Canc Ctr & Res Inst Tampa FL USA;
Henry Ford Hlth Syst Detroit MI USA;
Univ Calif San Francisco San Francisco CA 94143 USA;
Univ Alabama Birmingham Birmingham AL USA;
Johns Hopkins Sidney Kimmel Comprehens Canc Ctr Baltimore MD USA;
Dana Farber Canc Inst Boston MA 02215 USA|Harvard Med Sch Boston MA 02115 USA;
Dana Farber Canc Inst Boston MA 02215 USA|Harvard Med Sch Boston MA 02115 USA;
clinical trials; primary brain tumor; eligibility; inclusion criteria; exclusion criteria;
机译:自动分类临床试验中的资格标准,以促进特定患者群体的患者试验匹配
机译:现代化临床试验资格标准:美国临床肿瘤学会建议 - 癌症研究脑转移工作组
机译:衡量临床获益:在原发性脑肿瘤临床试验中使用患者报告的结果(pro)
机译:临床试验的自动分离与分类,改善患者资格匹配的临床试验
机译:参与抑郁症临床试验的患者动机:临床试验动机-抑郁症(MCTI-D)的开发和验证
机译:优化资格标准和临床试验以提高原发性脑肿瘤患者的临床试验
机译:自动分类临床试验中的资格标准,以促进特定患者群体的患者试验匹配